OVEX Fertility May Acquire Vaccine Maker
United Press International
MIAMI —
OVEX Fertility Corp. said it is engaged in preliminary talks concerning the acquisition of Selcore Laboratories Inc., a developer of vaccines.
The discussions have proposed an acquisition using about 1.7 million shares of OVEX stock representing about 38% of the shares outstanding after the transaction.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
